Underneath the Lost Kilos Imaging in Obesity and Metabolic Disease Drug Development From Muscle Preservation to Neuroprotection
Time: 3:10 pm
day: Day One
Details:
- Imaging methodologies (e.g. DXA, MRI, CT) provide information about different aspects of body composition meeting different needs in clinical trials
- Body composition assessment of muscle and adipose tissue can be combined with measures of other end-organ effects for a deeper understanding of treatment responses
- Imaging can be a very powerful tool, even in early PK or PD studies
